The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China

BACKGROUND: Despite recent advances through the development pipeline, how novel tuberculosis (TB) vaccines might affect rifampicin-resistant and multidrug-resistant tuberculosis (RR/MDR-TB) is unknown. We investigated the epidemiologic impact, cost-effectiveness, and budget impact of hypothetical no...

Descripción completa

Detalles Bibliográficos
Autores principales: Weerasuriya, Chathika K, Harris, Rebecca C, McQuaid, C Finn, Bozzani, Fiammetta, Ruan, Yunzhou, Li, Renzhong, Li, Tao, Rade, Kirankumar, Rao, Raghuram, Ginsberg, Ann M, Gomez, Gabriela B, White, Richard G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908776/
https://www.ncbi.nlm.nih.gov/pubmed/33632218
http://dx.doi.org/10.1186/s12916-021-01932-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908776/
https://www.ncbi.nlm.nih.gov/pubmed/33632218
http://dx.doi.org/10.1186/s12916-021-01932-7

Ejemplares similares